Core Scientific, Inc. Common Stock Cash Flow-to-Debt Ratio
Core Scientific, Inc. Common Stock cash flow-to-debt ratio. Core Scientific, Inc. Common Stock (CORZ) has a Cash Flow-to-Debt Ratio of 0.06x as of March 2026, meaning its operating cash flow of $249.88 Million could theoretically repay 0% of its total liabilities ($4.38 Billion) in one year. Check total reinvestment intensity of Core Scientific, Inc. Common Stock to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Core Scientific, Inc. Common Stock (2019–2025)
Cash flow-to-debt ratio of Core Scientific, Inc. Common Stock from 2019 to 2025. Historical debt coverage capacity for Core Scientific, Inc. Common Stock across 7 annual periods. Check Core Scientific, Inc. Common Stock earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Core Scientific, Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2019–2025)
Core Scientific, Inc. Common Stock cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Core Scientific, Inc. Common Stock. For the full cash flow conversion analysis, see Core Scientific, Inc. Common Stock (CORZ) cash conversion ratio.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | $278.25 Million | $3.31 Billion | ▲ +374.0% |
| 2024 | 0.02x | $42.90 Million | $2.42 Billion | ▼ -64.3% |
| 2023 | 0.05x | $65.11 Million | $1.31 Billion | ▼ -70.5% |
| 2022 | 0.17x | $205.19 Million | $1.22 Billion | ▲ +426.2% |
| 2021 | -0.05x | $-56.73 Million | $1.10 Billion | ▲ +80.0% |
| 2020 | -0.26x | $-23.77 Million | $91.88 Million | ▼ -713.3% |
| 2019 | -0.03x | $-832.00K | $26.16 Million | — |